BioHealth News
Unveiling the Future of Viral Safety: The 2024 PDA Virus Conference in Amsterdam
Dive into the world of viral safety with the upcoming 2024 PDA Virus Conference. Set against the picturesque backdrop of Amsterdam, this event promises…
Read More
Gaithersburg’s Georgiamune and Verily Announce Strategic Partnership to Advance Novel Cancer Treatment
GAITHERSBURG, Md. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Georgiamune, a privately held, clinical stage biotechnology company, and Verily, an Alphabet precision health technology company, today…
Read More
Altimmune Granted Fast Track Designation by FDA for Pemvidutide for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
GAITHERSBURG, Md., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA)…
Read More
Centers for Medicare & Medicaid Services Awards MITRE New Five-Year Contract to Continue Operating Health R&D Center
MCLEAN, Va. & BEDFORD, Mass.--(BUSINESS WIRE)--MITRE announced a new five-year contract with the Centers for Medicare & Medicaid Services (CMS) to operate the CMS…
Read More
Montgomery College Faculty Teams Win Three Grants from the National Science Foundation
Projects will broaden opportunities for traditionally underrepresented students in STEMIn a historic first for Montgomery College (MC), three different teams of faculty and administrators…
Read More
TEDCO announces new appointments for Maryland Venture Fund Authority
Maryland Venture Fund Authority advises and consults with TEDCO regarding the administration of the InvestMaryland program COLUMBIA, Md. (October 24, 2023) – TEDCO, Maryland’s…
Read More
Advancing infectious disease capabilities through biomedical research laboratory core support
Oct 23, 2023 -Farhang Alem, Interim Director of the Biomedical Research Laboratory, Institute for Biohealth Innovation, and Aarthi Narayanan, Professor, Biology, will receive more than $12 million from the…
Read More
Biden-Harris Administration Designates 31 Tech Hubs Across America Including Maryland & Virginia
As part of the President’s Investing in America agenda, the U.S. Department of Commerce identified regional centers primed for technological innovation and job creation.…
Read More
TEDCO Announces Investment into Sisu Global Health
Maryland-based, woman-owned biotech company providing hospitals with an autotransfusion device to address the global blood shortage COLUMBIA, Md. (October 23, 2023) – TEDCO, Maryland’s economic engine…
Read More
FDA Clears Rise Therapeutics’ IND Application to Initiate a Phase 1 Clinical Study
FDA Clears Rise Therapeutics' IND Application to Initiate a Phase 1 Clinical Study of Its Novel Oral Immunotherapy for the Treatment of Rheumatoid Arthritis…
Read More
Immunomic Therapeutics Reports Positive Results from Its Phase 1 Clinical Trial
Immunomic Therapeutics Reports Positive Results from Its Phase 1 Clinical Trial of ITI-3000 in Patients Diagnosed with Merkel Cell Carcinoma ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics,…
Read More
Qnovia Enters Collaboration with University of Virginia to Advance Inhaled Drug Candidates for Treating Infectious Diseases
RICHMOND, Va.--(BUSINESS WIRE)-- Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, today announced it has entered into a…
Read More
Baltimore’s MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD™, Reduced Acute Inflammatory Pain
- Supera-CBD eased heat-related pain due to inflammation quickly and provided long-lasting pain relief lasting up to five hours - Results suggest Supera-CBD may target specific…
Read More
Maryland Industrial Partnerships (MIPS) Program Provides Matching Grants for 17 Technology Development Projects Teaming Maryland Companies, USM Faculty
The Maryland Industrial Partnerships (MIPS) program announced that it is providing matching grants for 17 technology product development projects in Maryland. Each project pairs University System…
Read More
Ascentage Pharma and AstraZeneca Enter into Clinical Collaboration
Ascentage Pharma and AstraZeneca Enter into Clinical Collaboration on the Registrational Phase III Study of Bcl-2 Inhibitor Lisaftoclax in Combination with BTK Inhibitor Acalabrutinib…
Read More